A leading pro-life organization is urging Trump-era officials to step in as states like New York and California clamp down on “abortion pill reversal” protocols using progesterone. 40 Days for Life wrote to former HHS Secretary RFK Jr., DOJ’s Pam Bondi, and FDA chief Marty Makary, calling for federal protection for providers offering the service.
The group argues progesterone, a natural hormone that can halt the effects of mifepristone, is proven and safe—yet facing legal challenges in blue states. 40 Days for Life warned that these actions strip women of options under government fiat, urging the Trump-era team to shield clinicians “without fear of frivolous over‑bearing litigation”.
Progesterone’s role: it supports early pregnancy and may reverse medical abortion when used after mifepristone and before misoprostol. Its advocates ask Trump officials to codify protections ensuring doctors can offer it free from state prosecution.
Blue states have labeled the reversal protocol “unproven” or even fraudulent. Lawsuits led by states like New York and California target groups like Heartbeat International for allegedly deceptive claims—though supporters counter these are scientifically grounded.
This demand arrives amid a broader conservative push to curtail FDA-approved abortion pill access. A coalition dubbed “Rolling Thunder” is lobbying the Trump administration to restrict mifepristone via regulation or legislation—backed by anti-abortion legal forces.
For the Trump administration, this letter presents a chance to act on pro-life pledges—either by intervening in state litigation or tightening federal rule-making. For blue-state authorities, the move underscores a rising clash over who determines abortion legislation and standards of care.
